Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients
Clinical Endocrinology, 02/24/09
Ezzidi I et al. - This study suggests that IL-10 promoter polymorphism influence the risk of nephropathy in Tunisian T2DM patients.
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with the PPAR-gamma agonist rosiglitazone down-regulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
European Journal of Endocrinology, 11/24/09
Autoimmune Polyglandular Syndrome Type 2 With Myasthenia Gravis Crisis
The Neurologist, 11/20/09
Diabetes associated with autoimmune pancreatitis: new insights into the mechanism of beta-cell dysfunction
Expert Review of Endocrinology & Metabolism, 11/17/09
Sponsor
Article Search
Sponsor


See Latest Articles


